Drugs / VNP20009
Trials 3 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00006254 | May 2000 → Jan 2008 | cancer of unknown primary site | Vion Pharmaceuticals | Completed | No outcome recorded |
| Phase 1 | NCT00004988 | Mar 2000 → Oct 2002 | cancer, metastatic neoplasm | National Cancer Institute (NCI) | Completed | No outcome recorded |
| Phase 1 | NCT00004216 | Aug 1999 → Jan 2008 | cancer of unknown primary site | Vion Pharmaceuticals | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | VNP20009 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00006254 ↗ |
| Modality | Other / unclassified | “live, genetically modified Salmonella typhimurium (VNP20009)” NCT00004216 ↗ |
| Route | Other | “intratumorally injected live, genetically modified Salmonella typhimurium (VNP20009)” NCT00004216 ↗ |